The incidence of AIDS non-associated tumors is increasing year by year by unknown mechanisms, but is associated with immunodeficiency and possibly with prolonged survival of AIDS patients with HARRT treatment. Currently, there is no uniformity regarding the treatment protocols for non-associated malignancies of AIDS, such as the treatment protocol for AIDS combined with lung cancer. In the treatment of AIDS combined with lung cancer. 1. Are the treatment protocols for lung cancer suitable for AIDS combined with lung cancer lung cancer? 2.How to assess the annual survival rate and quality of life of AIDS combined with lung cancer? 3.Is radical surgery or palliative resection better for the surgical treatment of AIDS combined with lung cancer? 4. AIDS itself is an immunodeficiency disease, and chemotherapy in combination with lung cancer reduces immunity, so does the immunotherapy regimen need to be strengthened? Or should chemotherapy be given after immunotherapy? 5. Is it possible to treat patients with AIDS combined with lung cancer with allogeneic CIK, since most institutions in China refuse to administer cell therapy (CIK) to AIDS patients? 6. Since the mechanism of AIDS combined with lung cancer is still unclear, it is more necessary to implement molecular diagnosis of individualized tumor drug use to improve its efficacy! For the above problems, we have designed various plans (surgery, chemotherapy, cell therapy, individualized tumor drug molecular diagnosis, etc.) for patients with AIDS combined with lung cancer to choose from, welcome to visit us!